Market Tracker

10/17 5:16pm ET

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.20
Delayed Data
As of Oct 17
 +0.60 / +4.41%
Today’s Change
10.75
Today|||52-Week Range
19.90
-5.65%
Year-to-Date

Today’s Trading

Previous close13.60
Today’s open13.65
Day’s range13.60 - 14.35
Volume1,011,211
Average volume (3 months)758,175
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-295.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc+1.02+2.68%
SGMOSangamo Therapeutics...-0.35-2.36%
NDRMNeuroderm Ltd-0.05-0.13%
EPZMEpizyme Inc-0.10-0.56%
Data as of 3:59pm ET, 10/17/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer &
Chief Scientific Officer
Ganesh Venkataraman Kaundinya
Corporate headquarters
Cambridge, Massachusetts

Forecasts